Imprimis Pharmaceuticals, Inc.
| Nasdaq: IMMY
Imprimis Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the commercial development of novel drug formulations and proprietary drug delivery vehicles. It focuses on meeting unmet patient needs through the development and commercialization of innovative proprietary sterile and topical drug formulations and technologies that are customized for patients. Its network of innovators includes inventive physicians and pharmacists. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in San Diego, CA.